Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Fava

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Current Psychiatry Reports|April 29, 2010
Psychosomatic medicine is a comprehensive field, not a synonym for consultation liaison psychiatryGiovanni Andrea Fava, Carlotta Belaise, Nicoletta Sonino
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 28, 2002
Residual symptoms in depression: an emerging therapeutic targetGiovanni Andrea Fava, Stefania Fabbri, Nicoletta Sonino
International Journal of Psychiatry in Clinical Practice|July 28, 2020
Relapse prevention in recurrent major depressive disorder. A comparison of different treatment options based on clinical experience and a critical review of the literatureFiammetta Cosci, Giovanni Mansueto, Giovanni Andrea Fava
CNS Spectrums|July 14, 2010
The spectrum of adjustment disorders: too broad to be clinically helpfulFederica Semprini, Giovanni Andrea Fava, Nicoletta Sonino
Current Opinion in Rheumatology|January 25, 2023
An update on autoantibodies in systemic lupus erythematosusEduardo Gómez-Bañuelos, Andrea Fava, Felipe Andrade
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2024
ReplyAndrea Fava, Catriona A Wagner, Judith A James
Psychotherapy and Psychosomatics|September 25, 2013
Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysisEmanuela Offidani, Jenny Guidi, Elena Tomba, et al.
Lupus Science & Medicine|December 19, 2023
Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLEAaron Bao, Michelle A Petri, Andrea Fava, et al.
Rivista Di Psichiatria|April 21, 2018
The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliabilityFiammetta Cosci, Guy Chouinard, Virginie-Anne Chouinard, et al.
Lupus Science & Medicine|October 6, 2023
Does the use of corticosteroids and immunosuppressants increase the risk of COVID-19 infection among people with systemic lupus erythematosus?Laurence S Magder, Andrea Fava, Daniel Goldman, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Current Psychiatry Reports|April 29, 2010
Psychosomatic medicine is a comprehensive field, not a synonym for consultation liaison psychiatryGiovanni Andrea Fava, Carlotta Belaise, Nicoletta Sonino
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 28, 2002
Residual symptoms in depression: an emerging therapeutic targetGiovanni Andrea Fava, Stefania Fabbri, Nicoletta Sonino
International Journal of Psychiatry in Clinical Practice|July 28, 2020
Relapse prevention in recurrent major depressive disorder. A comparison of different treatment options based on clinical experience and a critical review of the literatureFiammetta Cosci, Giovanni Mansueto, Giovanni Andrea Fava
CNS Spectrums|July 14, 2010
The spectrum of adjustment disorders: too broad to be clinically helpfulFederica Semprini, Giovanni Andrea Fava, Nicoletta Sonino
Current Opinion in Rheumatology|January 25, 2023
An update on autoantibodies in systemic lupus erythematosusEduardo Gómez-Bañuelos, Andrea Fava, Felipe Andrade
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2024
ReplyAndrea Fava, Catriona A Wagner, Judith A James
Psychotherapy and Psychosomatics|September 25, 2013
Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysisEmanuela Offidani, Jenny Guidi, Elena Tomba, et al.
Lupus Science & Medicine|December 19, 2023
Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLEAaron Bao, Michelle A Petri, Andrea Fava, et al.
Rivista Di Psichiatria|April 21, 2018
The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliabilityFiammetta Cosci, Guy Chouinard, Virginie-Anne Chouinard, et al.
Lupus Science & Medicine|October 6, 2023
Does the use of corticosteroids and immunosuppressants increase the risk of COVID-19 infection among people with systemic lupus erythematosus?Laurence S Magder, Andrea Fava, Daniel Goldman, et al.
Pageof 8